Table 1 Eligibility criteria

Population

Clinicians e.g., doctors, nurses and allied health professions involved in managing gynaecological cancers

Adult female patients diagnosed with a gynaecological malignancy i.e., cervical, vulvar, vaginal, endometrial, or ovarian

Caregivers and/or relatives of patients described above

Intervention

Multimodal* interventions prior to surgery in isolation or in combination with an ERAS** intervention

Qualitative studies exploring views and opinions of prehabilitation (uni/multimodal) amongst gynaecological cancer patients

Comparator

Any intervention or usual care (within a randomised trial)

Outcomes

The facilitators and enablers to engagement in prehabilitation

The barriers to engagement and adherence with prehabilitation

The intended and unintended outcomes of participating in prehabilitation

The effectiveness of prehabilitation programmes

Healthcare context

Any setting that provides care to adult cancer populations e.g., hospital, ambulatory care, outpatient/ community care, primary care, digital platforms

Study design

Qualitative, quantitative, or mixed methods studies. If relevant existing systematic reviews are identified, their primary papers will be included. Published up to and including September 2021

Protocols for ongoing trials of relevant prehabilitation interventions which meet the inclusion criteria

Exclusion criteria

Population

Studies addressing tumour groups or sites other than those listed above in the inclusion criteria

Intervention

Interventions focussing on single pre-operative interventions which are not part of a multimodal approach

Study design

Social media posts, podcasts and blogs will be excluded

Language

Articles published in a language other than English. Translation from other languages will not be possible due to lack of resources